[144] AKAMAI TECHNOLOGIES INC SEC Filing

Rhea-AI Filing Summary

Akamai Technologies, Inc. (AKAM) Form 144 notice reports a proposed sale of 5,000 shares of common stock through Charles Schwab & Co., Inc. on 09/15/2025 on NASDAQ with an aggregate market value listed as $383,234.00.

The shares were originally acquired as RSU/PSU from Akamai on 02/21/2024 as equity compensation. The filer also reports a prior sale of 5,000 shares on 07/15/2025 generating gross proceeds of $388,700.00. The notice includes the required representation that the seller has no undisclosed material adverse information and references Rule 10b5-1 plan language if applicable.

Positive

• Full transaction details provided: acquisition date, nature (RSU/PSU), broker, exchange, quantities, and market values are all disclosed
• Compliance representation included: signer affirms no undisclosed material adverse information and references Rule 10b5-1 if applicable

Negative

• None.

Insights

Securities Analyst

TL;DR: Insider RSU sale planned: 5,000 shares for ~$383k scheduled; prior 5,000-share sale realized ~$388.7k.

The filing is a routine Form 144 disclosure showing a beneficial owner intends to sell shares acquired as equity compensation. The acquisition date and nature (RSU/PSU) and the broker and exchange are specified, which satisfies transfer notice requirements. The prior near-term sale of the same quantity is noted, indicating ongoing disposition of vested equity rather than a single large divestiture.

Corporate Governance Expert

TL;DR: Compliance-focused filing documenting an open-market sale via Schwab; includes mandatory certification about material nonpublic information.

The Form 144 contains the required attestations and transaction details: acquisition as equity compensation and sale logistics. From a governance perspective, the explicit representation about lack of undisclosed material information and the optional 10b5-1 reference are important for regulatory compliance. No unusual transfer terms or nonstandard consideration are disclosed.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Charles Schwab & Co., Inc. 3000 Schwab Way Westlake TX 76262	5000	383234.00	143385528	09/15/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/21/2024	RSU / PSU	AKAMAI TECHNOLOGIES INC			5000	02/21/2024	Equity Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
PAUL C JOSEPH 145 BROADWAY CAMBRIDGE MA 02142	AKAMAI TECHNOLOGIES INC	07/15/2025	5000	388700.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 for AKAM report?

The Form 144 reports a proposed sale of 5,000 Akamai common shares through Charles Schwab on 09/15/2025 with an aggregate market value of $383,234.00.

How were the shares being sold acquired?

The shares were acquired as RSU/PSU equity compensation from Akamai on 02/21/2024.

Has the filer recently sold other AKAM shares?

Yes. The filing discloses a sale of 5,000 shares on 07/15/2025 with gross proceeds of $388,700.00.

Which broker and exchange are indicated for the proposed sale?

The broker is Charles Schwab & Co., Inc. and the sale is planned on NASDAQ.

Does the Form 144 include compliance representations?

Yes. The filer represents they do not possess undisclosed material adverse information and may reference a Rule 10b5-1 plan if applicable.